Skip to main content

Advertisement

SpringerLink
Log in

Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

A Correction to this article was published on 01 April 2020

This article has been updated

Abstract

The major causes of emergence of multidrug-resistant organisms (MDRO) in neonatal sepsis include empiric antibiotic prescriptions, unregulated use of over-the-counter drugs, high incidence of healthcare associated infections (HAI), lack of awareness about antibiotic stewardship program and under staffing of neonatal intensive care units. In general, mortality due to MDRO sepsis is significantly higher as compared to non MDRO sepsis. Reported morbidities include prolonged use of total parenteral nutrition, need for central venous catheter, invasive ventilation, increased duration of hospital stay and neurologic sequelae.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 01 April 2020

    The article Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1, written by Chand Wattal, Neelam Kler, J. K. Oberoi, Anurag Fursule, Anup Kumar and Anup Thakur, was originally published electronically on the publisher���s internet portal (currently SpringerLink) on 11 December 2019 with open access.

References

  1. Klein JO. Bacteriology of neonatal sepsis. Pediatr Infect Dis J. 1990;9:778.

    CAS  PubMed  Google Scholar 

  2. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011;127:817–26.

    Article  Google Scholar 

  3. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388:3027–35.

    Article  Google Scholar 

  4. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–61.

    Article  Google Scholar 

  5. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.

    Article  Google Scholar 

  6. Deorari A, Agrawal R, Paul VK, Agrawal R, Upadhayay A, Chawla D GG. National Neonatal- Perinatal Database. NNPD Nodal Center AIIMS Delhi. New Delhi; 2005. Available at: https://www.newbornwhocc.org/pdf/nnpd_report_2002-03.PDF. Accessed 10 August 2019.

  7. Zaidi A, Thaver D, Ali S, Khan T. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28:S10–8.

  8. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002;110:285–91.

    Article  Google Scholar 

  9. Drug Resistance, Multiple, Bacterial - MeSH - NCBI [Internet]. Available at: https://www.ncbi.nlm.nih.gov/mesh/68024901. Accessed 9 August 2019.

  10. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.

    Article  CAS  Google Scholar 

  11. Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168–75.

    Article  Google Scholar 

  12. Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H. ARPEC Project Group. The worldwide antibiotic resistance and prescribing in European children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016;71:1106–17.

    Article  CAS  Google Scholar 

  13. WHO. GARDP Program Strategy Neonatal Sepsis: NeoAMR. 2016.

  14. WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003: Abbreviations, Acronyms & WHO Regions [Internet]. Available at: http://apps.who.int/medicinedocs/en/d/Jwhozip16e/2.html. Accessed 6 Aug 2019.

  15. Chaurasia S, Sivanandan S, Agarwal R, Ellis S, Sharland M, Sankar MJ. Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 2019;364:k5314.

  16. Yusef D, Shalakhti T, Awad S, Algharaibeh H, Khasawneh W. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review. Pediatr Neonatol. 2018;59:35–41.

  17. Wei HM, Hsu YL, Lin HC, et al. Multidrug-resistant Acinetobacter baumannii infection among neonates in a neonatal intensive care unit at a medical center in Central Taiwan. J Microbiol Immunol Infect. 2015;48:531–9.

  18. Li JY, Chen SQ, Yan YY, et al. Identification and antimicrobial resistance of pathogens in neonatal septicemia in China—a meta-analysis. Int J Infect Dis. 2018;71:89–93.

  19. Roy S, Datta S, Das P, et al. Insight into neonatal septicaemic Escherichia coli from India with respect to phylogroups, serotypes, virulence, extended-spectrum- β -lactamases and association of ST131 clonal group. Epidemiol Infect. 2015;143:3266–76.

  20. Datta S, Roy S, Chatterjee S, et al. A five-year experience of carbapenem resistance in enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1. PLoS One. 2014;9:e112101.

  21. Chatterjee S, Datta S, Roy S, et al. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to ISAba125. Front Microbiol. 2016;7:1126.

  22. Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Heal. 2016;4:e752–60.

  23. Jajoo M, Manchanda V, Chaurasia S, et al. Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India. PLoS One. 2018;13:e0180705.

  24. Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742–50.

  25. WHO. Antimicrobial Resistance [Internet]. Available at: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 30 July 2019.

  26. Smith RD, Coast J. Antimicrobial resistance: a global response. Bull World Health Org. 2002;80:126–33.

  27. WHO. 10 Facts on Antimicrobial Resistance [Internet]. WHO. World Health Organization; 2017. Available at: https://www.who.int/features/factfiles/antimicrobial_resistance/en/. Accessed 31 July 2019.

  28. Goswami N, Gandhi A, Patel P, Dikshit R. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Perspect Clin Res. 2013;4:130–5.

  29. Stapleton PJ, Murphy M, McCallion N, Brennan M, Cunney R, Drew RJ. Outbreaks of extended spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2016;101:F72–8.

  30. Butaye P, Devriese LA, Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin Microbiol Rev. 2003;16:175–88.

  31. Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133:e322–9.

  32. Oberoi JK, Wattal C. Neonatal sepsis: an outcome study at a tertiary care centre in New Delhi, India. Poster & Oral presentation presented at “1st Global Forum on Bacterial Infections” at New Delhi on 3–5 October 2011.

  33. Stone PW, Gupta A, Loughrey M, et al. Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003;24:601–6.

  34. Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20:973–80.

  35. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.

  36. Jinka DR, Gandra S, Alvarez-Uria G, Torre N, Tadepalli D, Nayakanti RR. Impact of antibiotic policy on antibiotic consumption in a neonatal intensive care unit in India. Indian Pediatr. 2017;54:739–41.

  37. Press Information Bureau, Ministry of Health and Family Welfare, India. Rules for Selling of Drugs Under Schedule H1 [Internet]. 2013. Available at: http://pib.nic.in/newsite/PrintRelease.aspx?relid=101251 . Accessed 1 Aug 2019.

  38. Dutta SS. India launches strategy to curb antimicrobial resistance. BMJ. 2017;357:j2049.

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Microbiology & Immunology, Sir Ganga Ram Hospital, New Delhi, India

    Chand Wattal & J. K. Oberoi

  2. Department of Neonatology, Sir Ganga Ram Hospital, New Delhi, India

    Neelam Kler, Anurag Fursule, Anup Kumar & Anup Thakur

Authors
  1. Chand Wattal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neelam Kler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. K. Oberoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anurag Fursule
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anup Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anup Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chand Wattal.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wattal, C., Kler, N., Oberoi, J.K. et al. Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1. Indian J Pediatr 87, 117–121 (2020). https://doi.org/10.1007/s12098-019-03106-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-019-03106-z

Keywords

Search

Navigation